Albumin remarkable properties become fully meaningful when albumin is transformed through a technology capable of precisely controlling its form, density, porosity, crosslinking structure, and degradation kinetics.

This is what the ALBUPAD technology achieves in a cost- and eco-efficient way: it converts native albumin into a highly functional biomaterial through a solvent-free process. By exploiting the intrinsic physicochemical behavior of albumin, ALBUPAD enables the production of solid matrices, films, microdiscs, and three-dimensional constructs that are uniform, stable, reproducible, and inherently biocompatible. The process provides levels of structural control that were previously unattainable for a non-modified protein-based material.

By combining biological safety, structural programmability, controlled diffusion capacity, predictable biodegradation, and adaptability to a wide range of medical applications, albumin shaped through ALBUPAD technology emerges as a new category of biomaterial: natural, programmable, and functionally exceptional. This positions it as a promising platform for drug delivery, resorbable implants, accidental or surgical wound healing, and advanced tissue engineering.